Get started
ORPEAOO

ORPEA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

ORP2 chart


Full chart

ORP2 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.64 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.618 EUR
Net income (FY)
‪−413.00 M‬ EUR
Revenue (FY)
‪5.64 B‬ EUR
Shares float
‪87.02 M‬
Beta (1Y)
1.89

Employees


Employees (FY)
‪83 K‬
Change (1Y)
‪+4.52 K‬ +5.76%
Revenue / Employee (1Y)
‪67.90 K‬ EUR
Net income / Employee (1Y)
‪−4.98 K‬ EUR

About EMEIS


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Laurent Guillot
Website
emeis-group.com
Headquarters
Puteaux
Founded
1995
ISIN
FR001400NLM4
FIGI
BBG00X8QHBB6
Emeis SA engages in the operation of geriatric healthcare facilities. It operates through the following geographical segments: France Benelux UK Ireland, Central Europe, Eastern Europe, Iberian Peninsula/Latin America, and Others. Its services include nursing homes, psychiatric care clinics, home care, and post-acute and rehabilitation clinics. The company was founded by Jean-Claude Marian in 1989 and is headquartered in Puteaux, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ORP2 news



No news here

Looks like there's nothing to report right now

Reload

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ORP2 highest yielding bonds


FR0011365634
Orpea 5,25% 04/12/2026
Yield to maturity
5.25%
Maturity date
Dec 4, 2026

See all ORP2 bonds 

Frequently Asked Questions


The current price of ORP2 is 10.542 EUR — it has increased by 1.99% in the past 24 hours. Watch ORPEA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange ORPEA stocks are traded under the ticker ORP2.
ORP2 stock has fallen by −10.14% compared to the previous week, the month change is a 0.97% rise, over the last year ORPEA has showed a −14.60% decrease.
We've gathered analysts' opinions on ORPEA future price: according to them, ORP2 price has a max estimate of 15.00 EUR and a min estimate of 7.90 EUR. Watch ORP2 chart and read a more detailed ORPEA stock forecast: see what analysts think of ORPEA and suggest that you do with its stocks.
ORP2 reached its all-time high on Jun 5, 2024 with the price of 14.126 EUR, and its all-time low was 4.684 EUR and was reached on Dec 17, 2024. View more price dynamics on ORP2 chart.
See other stocks reaching their highest and lowest prices.
ORP2 stock is 1.42% volatile and has beta coefficient of 1.89. Track ORPEA stock price on the chart and check out the list of the most volatile stocks — is ORPEA there?
Today ORPEA has the market capitalization of ‪1.70 B‬, it has increased by 12.57% over the last week.
Yes, you can track ORPEA financials in yearly and quarterly reports right on TradingView.
ORPEA is going to release the next earnings report on Sep 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ORP2 net income for the last half-year is ‪−155.94 M‬ EUR, while the previous report showed ‪−257.06 M‬ EUR of net income which accounts for 39.34% change. Track more ORPEA financial stats to get the full picture.
As of Apr 25, 2025, the company has ‪83 K‬ employees. See our rating of the largest employees — is ORPEA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORPEA EBITDA is ‪571.21 M‬ EUR, and current EBITDA margin is 12.33%. See more stats in ORPEA financial statements.
Like other stocks, ORP2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORPEA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORPEA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORPEA stock shows the buy signal. See more of ORPEA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.